In the beta-and gammaherpesviruses, a specialized complex of viral transcriptional activators 11 (vTAs) coordinate to direct expression of virus-encoded late genes, which are critical for viral 12 assembly and whose transcription initiates only after the onset of viral DNA replication. The 13 vTAs in Kaposi's sarcoma-associated herpesvirus (KSHV) are ORF18, ORF24, ORF30, ORF31, 14 ORF34, and ORF66. While the general organization of the vTA complex has been mapped, the 15 individual roles of these proteins, and how they coordinate to activate late gene promoters, 16 remains largely unknown. Here, we performed a comprehensive mutational analysis of the 17 conserved residues in ORF18, a highly interconnected vTA component. Surprisingly, the 18 mutants were largely selective for disrupting the interaction with ORF30 but not the other 19 three ORF18 binding partners. Furthermore, disrupting the ORF18-ORF30 interaction weakened 20 the vTA complex as a whole, and an ORF18 point mutant that failed to bind ORF30 was unable interactions between the late gene transcription components are critical for both the stability 35 and function of the complex. 36 37 genes (20, 21). 62
to complement an ORF18 null virus. Thus, contacts between individual vTAs are critical, as even 22 small disruptions in this complex result in profound defects in KSHV late gene expression. 23 24 Importance 25
Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiologic agent of Kaposi's sarcoma and 26 other B-cell cancers and remains a leading cause of death in immunocompromised individuals. 27
A key step in the production of infectious virions is the transcription of viral late genes, which 28 generates capsid and structural proteins and requires the coordination of six viral proteins that 29 form a complex. The role of these proteins during transcription complex formation and the 30 importance of protein-protein interactions are not well understood. Here, we focused on a 31 central component of the complex, termed ORF18, and revealed that disruption of its 32 interaction with even a single component of the complex (ORF30) prevents late gene 33 expression and completion of the viral lifecycle. These findings underscore how individual 34
Introduction 38
A broadly conserved feature of the lifecycle of dsDNA viruses is that replication of the 39 viral genome licenses transcription of a specific class of viral transcripts termed late genes. 40
There is an intuitive logic behind this coupling, as late genes encode proteins that participate in 41 progeny virion assembly and egress, and thus are not needed until newly synthesized genomes 42 are ready for packaging. Additionally, late gene transcription requires ongoing DNA replication, and in the gammaherpesviruses Kaposi's sarcoma-associated herpesvirus (KSHV) and Barr virus (EBV) the increase in template abundance appears insufficient to explain the robust 45 transcription of late genes whose products are required in large amounts (1). 46
While the mechanisms underlying late gene activation can vary across viral families, in 47 the beta-and gammaherpesviruses, late gene promoters are strikingly minimalistic and 48 primarily consist of a modified TATA box (TATT) and ~10-15 base pairs of variable flanking 49 sequence (2-5). Despite this sequence simplicity, their transcription requires a dedicated set of 50 at least six conserved viral transcriptional activators (vTAs) whose precise roles are only 51 beginning to be uncovered. In KSHV, the vTAs are encoded by open reading frames (ORFs) 18, 52 24,30, 31, 34, and 66 (6-15). The best characterized of the vTAs is a viral TATA-binding protein 53 (TBP) mimic, encoded by ORF24 in KSHV, which binds both the late gene promoter and RNA 54 polymerase II (Pol II) (4, 8, 16, 17) . Beyond the viral TBP mimic, the only other vTA with a 55 documented transcription-related function is pUL79 (homologous to KSHV ORF18) in human 56 cytomegalovirus (HCMV), which promotes transcription elongation at late times of infection 57 (18) . Roles for the remaining vTAs remain largely elusive, although the KSHV ORF34 protein and 58 its murine cytomegalovirus (MCMV) homolog pM95 may function as hub proteins, as they 59 interact with numerous other vTAs (7, 9, 19) . In addition to the six conserved vTAs, in EBV, the 60 kinase activity of BGLF4 (homologous to KSHV ORF36) also contributes to the expression of late 61 are critical for late gene transcription. In MCMV, mutation of conserved residues in pM91 66 (homologous to KSHV ORF30) that disrupt its interaction with pM79 (homologous to KSHV 67 ORF18) renders the virus unable to transcribe late genes (19) . Similarly, the interaction 68 between KSHV ORFs 24 and 34 can be abrogated by a single amino acid mutation in ORF24 69 which prevents late gene transcription (9) . Further delineating these contacts should provide 70 foundational information relevant to understanding vTA complex function. 71
The precise role of KSHV ORF18 in late gene transcription remains unknown, however it 72 is predicted to interact with four of the five other vTAs (ORFs 30, 31, 34, and 66), suggesting 73 that-like ORF34-it may play a central role in vTA complex organization (7, 9) . Here, we 74 performed an interaction screen of ORF18 mutants to comprehensively evaluate the roles of its 75 conserved residues in mediating pairwise vTA binding. We reveal that ORF30 is particularly 76 sensitive to mutation in ORF18, enabling isolation of mutants that selectively abrogate this 77 interaction while retaining the contacts between ORF18 and the other vTAs. Disrupting the 78 ORF18-ORF30 interaction not only prevents KSHV late gene transcription, but also appears to 79 weaken assembly of the remaining vTA complex. These findings underscore the key role that 80 ORF18 plays in late gene transcription and suggest that disrupting just one of its interactions 81 has a destabilizing effect on the vTA complex as a whole. 82
83

Results
84
ORF18 interacts with ORF30, ORF31, ORF34, and ORF66 85
Previous work using a split luciferase-based interaction screen suggested that ORF18 is 86 highly interconnected with other viral late gene activators, as it interacted with the majority of the proteins in the viral transcription pre-initiation complex (vPIC) (9). To independently 88 confirm the binding of ORF18 to ORFs 30, 31, 34, and 66 in the absence of other viral factors, 89 we assessed its ability to co-immunoprecipitate (co-IP) with each of these vTAs in transfected 90 HEK293T cells. Consistent with the screening data, ORF18-3xFLAG interacted robustly with C-91 terminal 2xStrep-tagged versions of ORF30, ORF31, and ORF66 ( Figure 1B , D, E). Furthermore, 92
we consistently observed that the expression of ORF30 was higher when co-expressed with 93 ORF18 than when transfected with vector control, suggesting that ORF18 may stabilize ORF30 94 ( Figure 1B ). Although ORF18-3xFLAG did not interact with ORF34 tagged on its C-terminus, the 95 interaction was recovered upon moving the 2xStrep tag to the N-terminus of ORF34 ( Figure 1C ). 96 97
An interaction screen of ORF18 mutants reveals the role of conserved residues in interactions 98
with the other vTAs 99
To evaluate the importance of the interaction between ORF18 and its individual vTA 100 contacts, we aimed to identify point mutations that disrupted binding to individual vTAs but did 101 not destroy the integrity of the complex. Since the late gene vTA complex is conserved across 102 the beta-and gammaherpesviruses we reasoned that the individual points of contact might 103 depend on conserved amino acid residues. We performed a multiple sequence alignment 104 between KSHV ORF18 and its homologs in five other beta-and gamma herpesviruses (MHV68 105 ORF18, HCMV pUL79, MCMV pM79, EBV BVLF1, and BHV ORF18) using MUSCLE (22). The 106 sequence alignment revealed 25 single conserved residues, including six pairs of adjacent 107 conserved residues, which are depicted in Figure 2A as a schematic of the primary structure of 108
ORF18 showing the positions of conserved residues. We mutated each of the 25 conserved residues to alanine in ORF18-3xFLAG and made double alanine mutations in the six cases of 110 adjacent conserved residues ( Figure 2A ). Each of these 31 mutants was screened individually 111 for the ability to interact with ORFs 30, 31, and 66 by co-IP followed by western blot (data not 112 shown). To account for differences in expression between the ORF18 mutants, we calculated 113 the co-IP efficiency of each of the mutants, as described in the methods. These data were used 114 to generate a heat map, which displays the pair-wise interaction efficiencies on a color scale 115 where lighter blocks represent reduced binding and darker blocks represents increased binding 116 relative to WT ( Figure 2B ). Overall, the data revealed that ORF30 was the most sensitive to 117 mutations in ORF18, as 24 out of the 31 mutants displayed reduced or no binding. ORF31 118 showed variable sensitivity to ORF18 mutation (with some mutants even increasing the 119 interaction efficiency), while the ORF66-ORF18 interaction was relatively refractory to the 120 ORF18 point mutations ( Figure 2B ). 121
We focused on the six ORF18 mutants that exhibited <10% co-IP efficiency, relative to 122 WT, with any vTA in our initial screen (L29A, E36A, L151A, W170A, E36A_L37A, and 123 W170A_G171A; highlighted in red in Figure 2A ). These were re-screened 3-4 independent times 124 in co-IP assays with vTA components ORFs 30, 31, 34, and 66, and the co-IP efficiencies were 125 calculated as described in the methods then plotted relative to values obtained for WT ORF18 126 ( Figure 3A -D). All six of these ORF18 mutants had severe defects in their ability to co-IP ORF30, 127 but none were consistently different than WT ORF18 for interaction with ORFs 31, 34, and 66 128 ( Figure 3B -D). Among the six mutants, ORF18 E36A_L37A and ORF18 W170A_G171A showed no 129 detectable binding to ORF30, with ORF18 E36A_L37A retaining near-WT levels of interaction with 130 the remaining vTAs.
ORF18 point mutants that weaken the interaction between ORF18 and ORF30 have a reduced 132 capacity to activate the K8.1 late gene promoter 133
A reporter assay has been developed in which the co-expression of the six individual 134 vTAs can specifically activate a KSHV (or EBV) late gene promoter in transfected HEK293T cells 135 (9, 10). We used this assay as an initial proxy for the ability of the six ORF18 mutants described 136 above to activate late gene transcription. HEK293T cells were co-transfected with each of the 137 vTAs, including either WT or mutant ORF18, and firefly luciferase reporter plasmids driven by 138 either the late K8.1 promoter or, as a control, the early ORF57 promoter ( Figure 4A ). A plasmid 139 containing constitutively expressed Renilla luciferase was co-transfected with each sample to 140 normalize for transfection efficiency. As expected, inclusion of WT ORF18 with the remaining 141 vTA complex resulted in specific activation of the K8.1 late promoter, but not of the early 142 ORF57 promoter ( Figure 4B ). ORF18 mutants L29A, E36A, and L151A modestly reduced 143 activation of the late promoter, whereas more significant defects were observed with mutants 144 W170A, E36A_L37A, and W170A_G171A ( Figure 4B ). Although ORF18 W170A_G171A had the most 145 pronounced transcriptional defect, this mutant showed somewhat more variability than 146 ORF18 E36A_L37A in its interactions with the other vTA components (Figures 3 & 4 ). Thus, we 147 considered ORF18 E36A_L37A to be the top candidate for selectively analyzing the importance of 148 the ORF18-ORF30 interaction for KSHV late gene transcription. 149 150
The interaction between ORF18 and ORF30 affects assembly of the vTA complex 151
The transcriptional defect of the ORF18 E36A_L37A mutant in the reporter assay could be 152 due to a defect in assembly of the complex or due to defects in downstream events. To distinguish between these possibilities, WT or mutant ORF18-3xFLAG was co-transfected into 154
HEK293T cells with each of the other Strep-tagged vTAs. We then performed an a-FLAG IP, 155 revealing that purification of WT ORF18 led to co-IP of the complete vTA complex including Pol 156 II, which has been shown to interact with ORF24 in KSHV (8) ( Figure 5 ). We noted that in this 157 assay ORF18 E36A_L37A was more weakly expressed than WT ORF18, so to compare complex 158 formation with equivalent amounts of each protein, we titrated down the amount of WT ORF18 159 to match the levels of ORF18 E36A_L37A . Similar to our observation in a pairwise co-IP ( Figure 1B Consistent with its late gene expression defect, neither the 18.stop nor the 190 18.stop.ORF18 E36A_L37A cell lines were able to produce progeny virions, whereas virion 191 production in the 18.stop.ORF18 WT cells was indistinguishable from the WT KSHV-infected iSLK 192 cells ( Figure 6C ). Collectively, these data demonstrate that the specific interaction between 193 ORF18 and ORF30 is essential for late gene expression and virion production during KSHV 194 infection. 195 196 The analogous mutation in HCMV pUL79 disrupts its interaction with pUL91 198
As shown in Figure 7A , the E36_L37 residues are conserved across the beta-and 199 gammaherpesvirus ORF18 homologs. To determine whether these amino acids are similarly 200 important in a betaherpesvirus, we engineered the corresponding double mutation in HCMV 201 pUL79 (pUL79 E48A_L49A -3xFLAG). Similar to our observation with KSHV ORF30, HCMV pUL91 202 protein expression was significantly decreased in the absence of its WT pUL79 binding partner 203 ( Figure 7B ). This is consistent with the idea that pUL79 binding stabilizes pUL91. Furthermore, 204 in co-IP assays we detected a robust interaction between pUL79 and pUL91, which was 205 impaired in the presence of pUL79 E48A_L49A , even when we accounted for the expression level 206 differences of pUL91 ( Figure 7B ). This suggests that the overall protein-protein interface may be 207 conserved in the analogous ORF18-ORF30 interaction across the beta-and 208 gammaherpesviruses. 209 210
Discussion 211
Elucidating the architecture of the six-member vPIC complex is central to understanding 212 the mechanism underlying viral late gene expression in beta-and gammaherpesviruses. 213
Although their functions are largely unknown, each of these viral transcription regulators is 214 essential for late gene promoter activation and evidence increasingly suggests that their ability 215 to form a complex is crucial for transcriptional activity (9, 10, 19). Here, we reveal that selective 216 disruption of an individual protein-protein contact between KSHV ORF18 and ORF30 within the 217 vPIC is sufficient to abrogate late gene transcription and virion production in infected cells, 218 emphasizing the sensitivity of the complex to organizational perturbation.
We selected ORF18 for mutational screening due to its ability to form pairwise 220 interactions with the majority of other vPIC components, which suggested that it might serve as 221 an organizational hub for vPIC assembly, similar to what has been proposed for ORF34 (7, 9) . 222 However, the 31 tested mutants of ORF18 revealed that conserved residues across the length 223 of the protein are extensively-and largely selectively-required for ORF30 binding. This is in 224 contrast to the interaction between the vPIC components ORF24 and ORF34, where the 225 interaction can be localized to a 17 amino acid stretch of ORF24 (9). The observation that the 226 majority of the ORF18 point mutations that disrupt the interaction with ORF30 do not affect its 227 binding to ORFs 31, 34, and 66 indicates that these mutations do not significantly alter the 228 overall folding or structure of ORF18. In MCMV, the organization of the vTA complex is similar 229 to KSHV, except that pM92 (homologous to KSHV ORF31) interacts with pM87 (homologous to 230 KSHV ORF24), whereas in KSHV this interaction is bridged through ORF34 (19). Our data 231 complement recent findings in MCMV, in which mutations of the ORF30 homolog (pM91) that 232 perturb the interaction with the ORF18 homolog (pM79) similarly cause a defect in the 233 expression of late genes (19). Thus, mutations that disrupt the ORF18-ORF30 protein-protein 234 interface in either protein cause the same phenotype. 235
The ORF18-ORF30 interaction appears sensitive to single amino acid changes in the 236 protein-protein interface. The ORF18 E36A_L37A mutation does not impair binding to its other vPIC 237 partners in pairwise co-IP experiments and ORF30 does not engage in pairwise interactions with 238 vPIC components other than ORF18 (7, 9). It is therefore notable that the efficiency of the vPIC 239 complex assembly is reduced in HEK293T cells in the presence of the ORF18 E36A_L37A mutant, 240 suggesting that the ORF18-ORF30 interaction contributes to the stability of the complex as a whole. The interaction between ORF18 and ORF30 may change the conformation of ORF18, 242 allowing it to interact more strongly with the other vTAs. 243
We observed that ORF30 protein expression was consistently higher in the presence of 244 WT ORF18 or ORF18 mutants that retained ORF30 binding, suggesting that ORF18 helps 245 stabilize ORF30. In silico protein stability prediction studies have suggested that protein stability 246 is in part affected by protein length, where proteins that are less than 100 amino acids tend to 247 be less stable (24, 25). One explanation for the higher expression of ORF30 in the presence of 248 ORF18 could therefore be that the 77 amino acid ORF30 is protected from degradation by 249 ORF18. Another possibility is that ORF18 helps keep ORF30 correctly folded-this has been 250
proposed as a mechanism that stabilizes proteins which have interaction partners (26). The 251 interaction-induced stability of a protein often correlates with the relative concentration of its 252 binding partners (26), as we observed when we titrated down the amount of ORF18 in the 253 context of the complete vTA complex. A similar observation has been made between KSHV 254 proteins ORF36 and ORF45, where ORF36 was dependent on the interaction with ORF45 for 255 stabilization (27). We did not observe a similar correlation with levels of the other ORF18-256 associated vPIC proteins, and thus their stability may not require protective interactions. We 257 also observed a stabilizing effect of pUL79 on pUL91, indicating this may be a conserved feature 258 of this interaction in other beta-and gammaherpesviruses. 259
The fact that the late gene expression defect of the ORF18 E36A_L37A mutant is 260 exacerbated in the context of the virus, compared to in the plasmid promoter activation assay, 261 likely reflects the fact that the plasmid assay measures basal promoter activation but misses 262 other regulatory components of this cascade. For example, the origin of lytic replication is required in cis for late gene expression in related gammaherpesviruses (3, 28) and the reporter 264 assay does not capture the important contribution of viral DNA replication towards late gene 265 expression. This may explain why some mutants that are defective for ORF30 binding (e.g. 266 L29A, E36A, L151A) retain partial plasmid promoter activity; perhaps some weak binding 267 between ORF18 and ORF30 enables basal activation of the promoter in a context where the 268 vPIC components are overexpressed. Alternatively, some of the mutations may cause ORF18 to 269 bind to ORF30 more transiently, but their vPIC interaction becomes stabilized in the presence of 270 a late gene promoter. 271
In summary, the absence of late gene transcription in the KSHV ORF18.stop-infected 272 cells complemented with ORF18 E36A_L37A may derive from a cascade of phenotypes: the failure 273 to recruit ORF30 to the vPIC, the ensuing reduction in the efficiency of overall vPIC complex 274 assembly, and the reduced stability of ORF30 (if it also has additional vPIC-independent 275 functions). Ultimately, generating antibodies that recognize the endogenous KSHV vPIC 276 components will enable these phenotypes to be explored further during infection. In addition, 277 information about the 3-dimensional structure of the vPIC would significantly enhance our 278 understanding of this unique transcription complex, as it is becoming increasingly clear that 279 even small disruptions to the complex dramatically impact completion of the viral lifecycle. 280 281
Materials and Methods 282
Plasmids and Plasmid construction 283
To generate ORF18-3xFLAG pCDNA4, ORF18 was subcloned into the BamHI and NotI sites of 284 pCDNA-3xFLAG. The point mutations in ORF18 were generated using two primer site-directed mutagenesis with Kapa HiFi polymerase (Roche) with primers 1-62 listed in Table 1 . All 286 subsequent plasmids described below were generated using InFusion cloning (Clontech) unless 287 indicated otherwise. To generate plasmid pLVX-TetOneZeo, zeocin resistance was PCR amplified 288 out of plasmid pLJM1-EGFP-Zeo with primers 63/64 (Table 1 ) and used to replace the 289 puromycin resistance in pLVX-TetOne TM -Puro (Clontech) using the AvrII and MluI restriction 290 sites. To generate pLVX-TetOneZeo-ORF18 WT -3xFLAG and pLVX-TetOneZeo-ORF18 E36A_L37A -291 3xFLAG, ORF18 WT -3xFLAG and ORF18 E36_37A -3xFLAG were PCR amplified from each respective 292 pCDNA4 plasmid using primers 71/72 and inserted into the EcoRI and BamHI sites of pLVX-293
TetOne-Zeo. To generate UL79-3xFLAG pCDNA4 and UL91-2xStrep pCDNA4, UL79 was PCR 294 amplified with primers 67/68 (Table 1) and UL91 was PCR amplified with primers 69/70 (Table  295 1) from HCMV Towne strain, which was kindly provided by Dr. Laurent Coscoy, and cloned into 296 the BamHI and NotI sites of 3xFLAG (Cterm) pCDNA4 or 2xStrep (Cterm) pCDNA4. UL79 E48A_L49A 297 was generated with two primer site-directed mutagenesis using Kapa HiFi polymerase with 298 primers 73/74 (Table 1) RTA (iSLK-BAC16) has been described previously (23). iSLK-BAC16-ORF18.stop cells that contain 312 a stop mutation in ORF18 were kindly provided by Dr. Ting-Ting Wu (6). iSLK-BAC16 and iSLK-313 BAC16-ORF18.stop were maintained in DMEM supplemented with 10% FBS, 1 mg/ml 314 hygromycin, and 1 µg/ml puromycin (iSLK-BAC16 media). iSLK-BAC16-ORF18.stop cells were 315 complemented by lentiviral transduction with ORF18 WT -3xFLAG or ORF18 E36A_L37A -3xFLAG. To 316 generate the lentivirus, HEK293T cells were co-transfected with pLVX-TetOneZeo-ORF18 WT -317 3xFLAG or pLVX-TetOneZeo-ORF18 E36A_L37A -3xFLAG along with the packaging plasmids pMD2.G 318 and psPAX2. After 48h, the supernatant was harvested and syringe-filtered through a 0.45 µm 319 filter (Millipore). The supernatant was diluted 1:2 with DMEM and polybrene was added to a 320 final concentration of 8 µg/ml. 1 x 10 6 iSLK-BAC16-ORF18.stop freshly trypsinized cells were 321 spinfected in a 6-well plate for 2 h at 500 x g. After 24 h the cells were expanded to a 10 cm 322 tissue culture plate and selected for 2 weeks in iSLK-BAC16 media supplemented with 325 323 µg/ml zeocin (Sigma). For DNA transfections, HEK293T cells were plated and transfected after 324 24 h at 70% confluency with PolyJet (SignaGen). 325 EDTA, 0.5% NP-40, and protease inhibitor (Roche)] and rotating them at 4 °C for 30 minutes. 330
Lysates were cleared by centrifugation at 21,000 x g for 10 min, then 1 mg (for pairwise 331 interaction IPs) or 2 mg (for the entire late gene complex IPs) of lysate was incubated with pre- Green Supermix (BioRad) on a QuantStudio3 Real-Time PCR machine with primers 75/76 (Table  360 1) for the KSHV ORF59 promoter and normalized to the level of GAPDH promoter with primers 361 77/78 (Table 1) plasmids, then subjected to co-IP using a-FLAG beads followed by western blot analysis with 533 the indicated antibody. To normalize for the difference in expression of pUL91 in the different 534 transfection conditions, the co-IP efficiency was multiplied by the fold expression of pUL91 in 535 the presence of WT pUL79 versus E48A_L49A UL79. Input represents 2.5% of lysate used for co-536 IP. Vinculin was used as a loading control. 537 WT  E36A_L37A  W170A_G171A  E36A  W170A  L29A  L151A  R158A_L159A  N63A  R158A  G171A  L191A  L159A  L151A_G152A  E176A  N146A  W81A  L37A  G130A  G214A  R180A  G152A  G145A  G145A_N146A  G228A  R74A_K75A  R74A  G65A  K75A  Y85A  L72A 
